AI
RGEN icon

Atria Investments’s Repligen RGEN Stock Holding History

Atria Investments’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$861K Buy
6,309
+396
+7% +$48.7K 0.01% 1195
2026
Q1 		$697K Buy
5,913
+861
+17% +$120K 0.01% 1271
2025
Q4 		$828K Buy
5,052
+2,000
+66% +$313K 0.01% 1171
2025
Q3 		$408K Sell
3,052
-151
-5% -$18.3K ﹤0.01% 1541
2025
Q2 		$398K Buy
3,203
+85
+3% +$10.8K ﹤0.01% 1545
2025
Q1 		$397K Buy
3,118
+200
+7% +$30.8K 0.01% 1476
2024
Q4 		$420K Sell
2,918
-284
-9% -$40.7K 0.01% 1418
2024
Q3 		$477K Buy
3,202
+1,295
+68% +$186K 0.01% 1348
2024
Q2 		$240K Buy
+1,907
New +$299K ﹤0.01% 1719
2023
Q4 		– Sell
-6,581
Closed -$1.05M – 929
2023
Q3 		$1.05M Buy
+6,581
New +$1.08M 0.02% 826
2021
Q4 		– Sell
-3,573
Closed -$1.03M – 876
2021
Q3 		$1.03M Buy
+3,573
New +$917K 0.02% 775

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Atria Investments's RGEN Position: Q2 2026 in Review

Atria Investments increased its Repligen (RGEN) stake by 6.7% in Q2 2026, buying an estimated $48.7K and bringing the position to 6,309 shares worth $861K. The position accounts for 0.01% of the portfolio, ranked #1195.

Atria Investments first reported a position in RGEN in Q3 2021 and has held it in 11 quarters since. The position peaked at $1.05M in Q3 2023. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Atria Investments held 6,309 shares of Repligen worth $861K as of Q2 2026.
  • Atria Investments bought 396 Repligen shares in Q2 2026, an estimated $48.7K.
  • Repligen made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1195 holding.
  • Atria Investments first reported a position in Repligen in Q3 2021 and has held it in 11 quarters since.
  • Atria Investments's Repligen position peaked at $1.05M in Q3 2023.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.